Pulmonary Disease (COPD): Teaching Plan By: Michele Combs‚ RN NSG 405 February 7‚ 2011 Teaching Plan for Chronic Obstructive Pulmonary Disease Chronic obstructive pulmonary disease (COPD) is the 4th leading cause of death in the United States and is a major cause of morbidity (CDC‚ 2011). COPD is a group of diseases which cause airflow blockage and breathing related problems such as emphysema‚ chronic bronchitis‚ and some forms of asthma (CDC‚ 2011). COPD kills more than 120
Premium Chronic obstructive pulmonary disease Asthma
corticosteroids in COPD In this study published in JAMA‚ the authors looked at eleven studies on the use of inhaled corticosteroids in patients with COPD defined as a smoking- related lung disease characterized by recurrent episodes of cough‚ sputum production and breathlessness (Drummond‚ 2407). The authors of this study did no research of their own‚ but instead looked at other double blind‚ randomized‚ placebo controlled studies from around the world‚ with a restriction that the study was published
Premium 3rd millennium Chronic obstructive pulmonary disease Asthma
some cases‚ to slow down the progression of the disease process. However‚ patient education goes beyond the main objective. An informed and educated patient can actively contribute in his or her own therapy‚ improve results‚ help detect mistakes before they happen‚ and decrease length of hospital stay. There are several patient education opportunities that a respiratory therapist (RT) can initiate‚ including but not limited to: diagnostic procedural‚ home care‚ pulmonary rehabilitation‚ COPD exacerbation
Premium Health care Medicine Health care provider
COM155-University of Phoenix COPD and Heart Disease Chronic Obstructive Pulmonary Disease (COPD) and heart disease are two of the deadliest chronic illnesses affecting the world’s population. These diseases have caused hundreds of thousands to lose their lives. With the death rate of heart disease and COPD rising‚ attention should be focused on these diseases and how we can prevent fatalities throughout the world. Educating the public about these diseases is vital in lowering the
Premium Mortality rate Chronic obstructive pulmonary disease Death
Disease (COPD). This will be achieved by bringing the reader through the patients’ illness journey. The assignment will begin by defining COPD and briefly going through the pathophysiology and incidents of the condition. From there the reader will embark on the journey‚ starting with diagnosis. The author will attempt to give an in-depth exploration of the next stage‚ living for today while also discussing the Health Care Professionals’ role in providing a holistic approach to care. As COPD is a
Premium Management Marketing German language
disease Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease that results in obstructed airflow from the lungs. When a person takes a breath‚ air travels down the windpipe into airways. These airways scatter into smaller‚ much thinner tubes that end in a bunch of tiny air sacs. These air sacs stretch and inflates when a person breathes in and then deflates when the person breathes out. When a patient is diagnosed with COPD‚ their lung function is greatly lessened with air
Premium Asthma Chronic obstructive pulmonary disease Pulmonology
COPD: Chronic Obstructive Pulmonary Disease Angelia Alleyne HCS/245 May 4‚ 2015 Professor Lori Olson COPD: Chronic Obstructive Pulmonary Disease Chronic obstructive pulmonary disease‚ or COPD‚ is a long-term disease that causes breathing problems. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. COPD‚ however‚ is a heterogeneous collection of diseases with differing causes‚ pathogenic mechanisms‚ and physiological effects. Therefore a comprehensive approach
Premium Asthma Chronic obstructive pulmonary disease Pneumonia
Treatment for COPD Inhaled Therapies NICE COPD guidelines have made specific recommendations regarding the use of inhaled long-acting bronchodilators and inhaled steroids separately and in combination‚ but newer studies have assessed these drugs singly and in combination over longer periods of time. Bronchodilators (relievers) Short-acting beta2 agonists (SABA) Beta2 agonists act directly on bronchial smooth muscle to cause bronchodilation. They are the most widely used bronchodilators for COPD. Short-acting
Premium Chronic obstructive pulmonary disease Asthma
clients’ knowledge. In particular‚ I planned to increase the staff’s and the client’s (who has COPD) knowledge on COPD. I was determined to do this because of the observations I made while in the group home. To begin with‚ my preceptor informed me herself that she and the staff do not know much about COPD (e.g.‚ pathophysiology‚ symptoms‚ and interventions). Also‚ I observed the client’s lack of knowledge about COPD management such that he rarely drank water nor washed his hands before meals. These behaviors
Premium Health care Medicine Patient
COPD Respiratory disease paper Jean Izean HCS/245 May 25‚ 2015 Tynan Mara There are various forms of respiratory disease that not only debilitate‚ but claim the lives of millions of Americans each year. Chronic obstructive pulmonary disease‚ Tuberculosis‚ Lung cancer‚ Asthma‚ emphysema‚ and bronchitis are just a few of the common respiratory infections that disrupt the functions of organs and tissues responsible for providing oxygen to the body. In this paper I will discuss Chronic obstructive
Premium Chronic obstructive pulmonary disease Pulmonology Pneumonia